Today: 9 April 2026
$100 B Bank Fraud Scandal Triggers Global Market Rout – DAX Sinks Below 24,000 Amid ‘Cockroach’ Fears

DAX Today (10 November 2025): German Stocks Jump on U.S. Shutdown Progress; Siemens Energy, Commerzbank, Hannover Re Lead Gains

Berlin/Frankfurt — Monday, 10 November 2025. Germany’s blue‑chip DAX rallied at the start of the week as global risk appetite improved on signs the historic U.S. government shutdown could soon end. Shortly after the Xetra open, the DAX added about 1.4% to 23,907, with gains later stretching to ~23,990 (+1.8%) as buyers broadened out across financials, industrials and energy tech. The MDAX and Euro Stoxx 50 also traded firmly higher. marketscreener.com+1

Why the DAX is higher today

Relief across global markets followed U.S. Senate progress on a stopgap funding bill to reopen the federal government after a 40‑day shutdown, easing a key macro overhang for investors and reviving hopes for a “year‑end rally.” European indices tracked the upswing, with tech and cyclical shares out front. reuters.com

Market snapshot — Germany and Europe (mid‑session)

Note: Index levels are intraday and subject to change.

Biggest movers on the DAX

  • Siemens Energy+~5% after Jefferies upgraded the stock to Buy and lifted the price target to €134, citing sustained demand for grid and power solutions tied to data‑center load growth. reuters.com+1
  • Commerzbank+~5–6%, buoyed by fresh buy recommendations that helped push the lender to the top of the index. marketscreener.com
  • Hannover Re+~3–4% after the reinsurer raised 2025 net income guidance to ~€2.6bn on strong nine‑month results and a tighter combined ratio. reinsurancene.ws+1
  • Daimler Truck and Heidelberg Materials+3–4%, adding cyclical breadth to the rally. marketscreener.com
  • Laggards: E.ON and Deutsche Telekom edged lower, leaving utilities and telecoms among the few red spots. marketscreener.com

Beyond the megacaps, Northern Data surged after Rumble agreed to acquire the German AI‑cloud company in an all‑stock deal valued at roughly $767 million; the stock spiked on the headline and supportive terms disclosed. reuters.com+1

Macro picture: sentiment data mixed, chemicals under pressure

Fresh surveys paint a nuanced backdrop:

  • Eurozone Sentix investor morale fell to −7.4 in November (from −5.4), below expectations, underscoring a sluggish growth pulse despite today’s risk‑on tone. Germany’s sub‑index weakened as forward expectations slipped back below zero. reuters.com
  • Germany’s chemical industry sentiment plunged in October, per ifo, with the order‑backlog index dropping to a 30‑year low (−68.9) and capacity utilisation down to 71%—far below the 85% level analysts view as margin‑normalising. Sector bellwethers have trimmed guidance amid cost and competitiveness headwinds. reuters.com

The market rally suggests investors are presently prioritising the policy overhang in Washington and positioning for year‑end flows over soft spot indicators in Europe.

Rates & FX: Bund yields tick up, euro steadies

Benchmark 10‑year Bund yields nudged up toward a one‑month high near ~2.70%, mirroring moves in U.S. Treasuries as shutdown relief cooled safe‑haven demand. The euro hovered just under $1.16 against the dollar. tradingview.com+1

Earnings & news driving single stocks

  • Hannover Re (HNR1): lifted FY2025 net‑income target to ~€2.6bn (from €2.4bn), citing robust nine‑month profit growth and improved underwriting. The company also flagged a combined ratio below 87%. Shares gained on the outlook upgrade. reinsurancene.ws+1
  • Siemens Energy (ENR): broker upgrade to Buy with a sharp PT hike to €134 added momentum to a stock already benefiting from grid‑investment tailwinds tied to AI‑driven power demand. tradingview.com
  • Northern Data (NB2): Rumble to acquire the Frankfurt‑listed AI cloud group in an all‑stock transaction; Northern Data holders to receive 2.0281 Rumble Class A shares per share, with completion eyed for Q2 2026. reuters.com

What to watch next

  • U.S. shutdown bill: Traders are watching the House and White House for the next steps; a smooth resolution would keep risk appetite supported, while setbacks could quickly re‑price optimism. reuters.com
  • Data diary: Focus this week includes euro‑area growth prints and more Q3 corporate updates across Europe. reuters.com
  • German corporate calendar: Deutsche Telekom reports Q3 2025 on Thursday, 13 Nov, a key read for domestic telco trends. telekom.com

Bottom line

The German stock market is firmly higher on 10 November 2025, powered by policy relief from Washington and broker‑driven strength in heavyweights like Siemens Energy and Commerzbank, while Hannover Re’s guidance hike adds fundamental support. Softer sentiment surveys and pockets of industrial weakness (notably chemicals) remain the counterweight—but for now, momentum and seasonality are with the bulls. reuters.com+2reuters.com+2


Editor’s note for publishers: This article is written for Google News/Discover with clear date stamps, descriptive sub‑heads, entity‑rich keywords (DAX, Xetra, MDAX, Euro Stoxx 50, Bund yields, EUR/USD), and authoritative sourcing. If you update intraday levels before publishing, refresh the index snapshots accordingly.

CEO of TS2 Space and founder of TS2.tech. Expert in satellites, telecommunications, and emerging technologies, covering trends in space, AI, and connectivity.

Stock Market Today

  • Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate
    April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow projections turning positive by 2026. However, actual cash flow remains negative at $501.5 million last year. Investors must weigh DCF optimism against market risks and sector volatility. Ultragenyx scores 4 out of 6 in valuation, indicating some appeal but highlighting areas needing scrutiny.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:16 AM EDT Ultragenyx Pharmaceutical Shares Surge 8.1% Weekly Amid Valuation Debate April 9, 2026, 2:08 AM EDT. Ultragenyx Pharmaceutical (RARE) shares rose 8.1% last week to $23.15 amid mixed performance, down 1.9% year-to-date and 31.7% over 12 months. The biotech specializes in rare disease treatments, a sector sensitive to clinical trial and regulatory updates. Despite recent gains, the company's long-term returns remain negative. A discounted cash flow (DCF) analysis values Ultragenyx at about $257.43 per share, suggesting it is 91% undervalued based on future free cash flow
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Dakar Port Launches Electronic Delivery Voucher Pilot to Digitize Cargo Clearance — Go‑Live Slated for January 2, 2026
Previous Story

Dakar Port Launches Electronic Delivery Voucher Pilot to Digitize Cargo Clearance — Go‑Live Slated for January 2, 2026

FTSE 100’s Record Run: Inside London’s Blue-Chip Rally and What’s Next
Next Story

FTSE 100 Jumps on US Shutdown Hopes as Diageo Soars; BoE Stablecoin Plan and Gold Rally Lift London Stocks — UK Market Wrap (10 November 2025)

Go toTop